160 related articles for article (PubMed ID: 16586498)
21. CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survival.
Ogawa S; Yamaguchi M; Oka K; Taniguchi M; Ito M; Nishii K; Nakase K; Ohno T; Kita K; Kobayashi T; Shiku H
Br J Haematol; 2004 Apr; 125(2):180-6. PubMed ID: 15059140
[TBL] [Abstract][Full Text] [Related]
22. [International prognostic index in diffuse B large cell lymphosarcoma].
Magomedova AU; Vorob'ev AI
Ter Arkh; 2008; 80(3):71-6. PubMed ID: 18441690
[TBL] [Abstract][Full Text] [Related]
23. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas.
Sonnen R; Schmidt WP; Müller-Hermelink HK; Schmitz N
Br J Haematol; 2005 May; 129(3):366-72. PubMed ID: 15842660
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of prognostic factors in 74 cases of diffuse large B-cell lymphoma].
Wang J; Ke XY; Zhao LZ; Li M; Jing HM; Wang JJ; Zhao W; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):667-70. PubMed ID: 18399171
[TBL] [Abstract][Full Text] [Related]
25. Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
García-Suárez J; Bañas H; Arribas I; De Miguel D; Pascual T; Burgaleta C
Br J Haematol; 2007 Jan; 136(2):276-85. PubMed ID: 17233819
[TBL] [Abstract][Full Text] [Related]
26. TNF-α expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified.
Nakayama S; Yokote T; Hirata Y; Akioka T; Miyoshi T; Hiraoka N; Iwaki K; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
Am J Surg Pathol; 2014 Feb; 38(2):228-34. PubMed ID: 24145654
[TBL] [Abstract][Full Text] [Related]
27. Testicular lymphoma--a retrospective, population-based, clinical and immunohistochemical study.
Hasselblom S; Ridell B; Wedel H; Norrby K; Sender Baum M; Ekman T
Acta Oncol; 2004; 43(8):758-65. PubMed ID: 15764222
[TBL] [Abstract][Full Text] [Related]
28. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
30. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.
Davis FG; McCarthy BJ; Freels S; Kupelian V; Bondy ML
Cancer; 1999 Jan; 85(2):485-91. PubMed ID: 10023719
[TBL] [Abstract][Full Text] [Related]
31. Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
Hershman DL; McBride RB; Eisenberger A; Tsai WY; Grann VR; Jacobson JS
J Clin Oncol; 2008 Jul; 26(19):3159-65. PubMed ID: 18591554
[TBL] [Abstract][Full Text] [Related]
33. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation.
Qi SN; Li YX; Wang H; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Zhou LQ; Yu ZH
Cancer; 2009 Nov; 115(21):4980-9. PubMed ID: 19634158
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
35. Prognostic biomarkers in diffuse large B-cell lymphoma.
Lossos IS; Morgensztern D
J Clin Oncol; 2006 Feb; 24(6):995-1007. PubMed ID: 16418498
[TBL] [Abstract][Full Text] [Related]
36. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
37. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
[TBL] [Abstract][Full Text] [Related]
38. Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
Rodriguez R; Nademanee A; Ruel N; Smith E; Krishnan A; Popplewell L; Zain J; Patane K; Kogut N; Nakamura R; Sarkodee-Adoo C; Forman SJ
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1326-34. PubMed ID: 17162215
[TBL] [Abstract][Full Text] [Related]
39. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
[TBL] [Abstract][Full Text] [Related]
40. Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Tomita N; Motomura S; Hyo R; Takasaki H; Takemura S; Taguchi J; Fujisawa S; Ogawa K; Ishigatsubo Y; Takeuchi K
Cancer; 2007 Mar; 109(6):1146-51. PubMed ID: 17311304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
